Tight Glycemic Control by Artificial Pancreas

Kochi University32 enrolled

Overview

This study evaluated a closed-loop system providing continuous monitoring and strict control of perioperative blood glucose following pancreatic resection.

This study recruited 32 patients undergoing elective pancreatic resection for pancreatic disease.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Pancreatic Neoplasm

Interventions

Artificial Pancreas (STG-22)DEVICE

safe tool

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * This study recruited 32 patients undergoing elective pancreatic resection for pancreatic disease. Exclusion Criteria: * weight loss greater than 10% during the previous 6 months * signs of distant metastasis * respiratory, renal,or heart disease * Patients provided written informed consent prior to enrollment

Locations (1)

Kochi Medical School, Kochi University

Nankoku, Kohasu-Okocho, Japan

Outcomes

Primary Outcomes

the incidence of severe hypoglycemia (< 40 mg/dl) during the intensive care period following pancreatic resection in patients monitored using the artificial pancreas

Time frame: the first postoperative 18 hours in the surgical intensive care unit

Secondary Outcomes

the total amount of insulin required for glycemic control after pancreatic resection

Time frame: the first postoperative 18 hours in the surgical intensive care unit

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.